Jack Syage - President & COO, Director at Entero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & COO, Director
Stock Symbol
ENTO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jack Syage since 11/21/2023

Holdings reported by Jack Syage for Entero Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.0001 per share 15.4K Mar 13, 2024 Indirect
Series G Non-Voting Convertible Preferred Stock 4.92K Mar 13, 2024 Indirect Common Stock, par value $0.0001 per share

Transactions reported by Jack Syage for Entero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.